Kate Weyman
Clinical Instructor in Nursing; Nurse Practitioner; Certified Diabetes Educator
Research & Publications
Biography
Coauthors
Selected Publications
- 1199-P: Tackling Transition of Care of Young Adults with Type 1 Diabetes—Preliminary FindingsDIAS A, CONSIDINE E, WEYMAN K, CARR D, TICHY E, SHERR J. 1199-P: Tackling Transition of Care of Young Adults with Type 1 Diabetes—Preliminary Findings. Diabetes 2024, 73 DOI: 10.2337/db24-1199-p.
- Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1cSamuels S, Chajecki A, Hu P, Kayser M, Weyman K, Pan B, Brown E, Van Name M, Wolf R. Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c. Diabetes Obesity And Metabolism 2024, 26: 1305-1313. PMID: 38229444, DOI: 10.1111/dom.15430.
- 1100-P: Real-World Use of GLP-1 Agonists in Youth with Type 2 Diabetes Is Associated with Improvements in Hemoglobin A1c—A Multicenter AnalysisSAMUELS S, CHAJECKI A, HU P, KAYSER M, WEYMAN K, PAN B, BROWN E, VAN NAME M, WOLF R. 1100-P: Real-World Use of GLP-1 Agonists in Youth with Type 2 Diabetes Is Associated with Improvements in Hemoglobin A1c—A Multicenter Analysis. Diabetes 2023, 72 DOI: 10.2337/db23-1100-p.
Clinical Trials
Conditions | Study Title |
---|---|
Diabetes Mellitus - Type 1; Diabetes Mellitus - Type 2 | FreeStyle Libre 2 Flash Glucose Monitoring System Intervention Phase Study for Pediatric Patients |
Diabetes Mellitus - Type 1 | TrialNet TOPPLE Study for People with Type 1 Diabetes |
Diabetes Mellitus - Type 1 | Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22) |
Children's Health; Diabetes Mellitus - Type 1; Diseases of the Endocrine System | Pathway to Prevention Study |